Xbrane Biopharma Stock

Xbrane Biopharma ROA

The Return on Assets (ROA) of Xbrane Biopharma (XBRANE.ST) as of Aug 20, 2026 is 18.95 %. In the previous year, Return on Assets (ROA) was -31.60 % — a change of -159.95% (higher).

ROA

18.95 %

YoY

-159.95%

Last updated:

In 2026, Xbrane Biopharma's return on assets (ROA) was 18.95 %, a -159.95% increase from the -31.60 % ROA in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Xbrane Biopharma Stock analysis

What does Xbrane Biopharma do? Xbrane Biopharma is one of the most popular companies on Eulerpool.

ROA Details

Understanding Xbrane Biopharma's Return on Assets (ROA)

Xbrane Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Xbrane Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Xbrane Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Xbrane Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Xbrane Biopharma stock

Return on Assets (ROA) of Xbrane Biopharma is 18.95 % in 2026.

Return on Assets (ROA) of Xbrane Biopharma changed from -31.60 % to 18.95 %, representing a -159.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Xbrane Biopharma since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Xbrane Biopharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Xbrane Biopharma

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Xbrane Biopharma